Viewing StudyNCT00297102



Ignite Creation Date: 2024-05-05 @ 4:42 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00297102
Status: COMPLETED
Last Update Posted: 2017-01-16
First Post: 2006-02-27

Brief Title: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease COPD The AURA Study BY217M2-124
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Chronic Obstructive Pulmonary Disease COPD
Keywords:
Name View
Chronic obstructive pulmonary disease View
Roflumilast View
COPD View